Birdwatch Note Rating
2025-06-06 19:53:39 UTC - NOT_HELPFUL
Rated by Participant: B6FF1D611B88BDA77FEF8B3B039AA5261963145D68CBB71832B7E1454F78757E
Participant Details
Original Note:
Remdesivir did not increase risk of death from Ebola, but it was inferior to other studied treatments in the treatment of Ebola. About 53% of patients receiving remdesivir died from Ebola in the trial compared to 35% with the superior therapeutics. https://www.nih.gov/news-events/news-releases/investigational-drugs-reduce-risk-death-ebola-virus-disease https://pmc.ncbi.nlm.nih.gov/articles/PMC7250494
All Note Details